Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Brivaracetam by UCB for Epilepsy: Likelihood of Approval
Brivaracetam is under clinical development by UCB and currently in Phase III for Epilepsy. According to GlobalData, Phase III drugs...